Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.47 - $0.89 $253 - $480
540 New
540 $0
Q4 2021

Feb 08, 2022

SELL
$3.43 - $4.22 $43,430 - $53,433
-12,662 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$3.39 - $4.34 $42,490 - $54,397
12,534 Added 9792.19%
12,662 $50,000
Q2 2021

Sep 13, 2021

BUY
$4.03 - $5.07 $515 - $648
128 New
128 $1,000

About BIOCEPT INC


  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.